Betaine Anhydrous
Payments companies reported to CMS as associated with Betaine Anhydrous. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Betaine Anhydrous, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Betaine Anhydrous
These are the largest totals companies reported as associated with Betaine Anhydrous. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Edward Tabor | Bethesda, MD | Pediatrics | $5,160.00 |
| Sammy Saab | Los Angeles, CA | Gastroenterology (Internal Medicine) | $3,000.00 |
| Valentina Medici | Sacramento, CA | Gastroenterology (Internal Medicine) | $2,000.00 |
| Hrishikesh Samant | Shreveport, LA | Gastroenterology (Internal Medicine) | $1,024.60 |
| Walid Ayoub | West Hollywood, CA | Hepatology | $1,000.00 |
| Beshoy Yanny | Los Angeles, CA | Transplant Hepatology | $1,000.00 |
| Prasun Jalal | Houston, TX | Transplant Hepatology | $1,000.00 |
| Ahmet Gurakar | Baltimore, MD | Gastroenterology (Internal Medicine) | $1,000.00 |
| Joshua Yang | Orlando, FL | Pediatric Endocrinology | $518.75 |
| Rima Fawaz | New Haven, CT | Pediatric Gastroenterology | $500.00 |
Prescribed Betaine Anhydrous?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.